26-Hydroxycholesterol

26-Hydroxycholesterol is a lipid of Sterol Lipids (ST) class. 26-hydroxycholesterol is associated with abnormalities such as Cardiovascular Diseases, Vascular Diseases, Metabolic syndrome, Obesity and Fatty Streak, Arterial. The involved functions are known as Oxidation, phospholipase activity, glucose metabolism, Binding (Molecular Function) and Regulation. 26-hydroxycholesterol often locates in Immune system, Body tissue, Extracellular, Protoplasm and Back. The associated genes with 26-Hydroxycholesterol are Homologous Gene, chylomicron remnant, Receptor Gene, Alleles and D3 compound. The related lipids are 27-hydroxycholesterol, Hydroxycholesterols, Lysophosphatidylcholines, Total cholesterol and Lipopolysaccharides. The related experimental models are Knock-out and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of 26-Hydroxycholesterol, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with 26-Hydroxycholesterol?

26-Hydroxycholesterol is suspected in hypercholesterolemia, Obesity, Atherosclerosis, Metabolic syndrome, Neurodegenerative Disorders, Dyslipidemias and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with 26-Hydroxycholesterol

MeSH term MeSH ID Detail
Inflammation D007249 119 associated lipids
Hypercholesterolemia D006937 91 associated lipids
Alzheimer Disease D000544 76 associated lipids
Alcoholism D000437 27 associated lipids
Niemann-Pick Diseases D009542 25 associated lipids
Plaque, Amyloid D058225 19 associated lipids
Xanthomatosis, Cerebrotendinous D019294 14 associated lipids
Total 7

PubChem Associated disorders and diseases

What pathways are associated with 26-Hydroxycholesterol

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with 26-Hydroxycholesterol?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with 26-Hydroxycholesterol?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with 26-Hydroxycholesterol?

Transgenic Model

Transgenic Model are used in the study 'Cholesterol and breast cancer pathophysiology.' (Nelson ER et al., 2014) and Transgenic Model are used in the study 'Obesity, cholesterol metabolism, and breast cancer pathogenesis.' (McDonnell DP et al., 2014).

Knock-out

Knock-out are used in the study 'The cholesterol metabolite 27-hydroxycholesterol promotes atherosclerosis via proinflammatory processes mediated by estrogen receptor alpha.' (Umetani M et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with 26-Hydroxycholesterol

Download all related citations
Per page 10 20 50 100 | Total 403
Authors Title Published Journal PubMed Link
Desmarchelier C et al. C57Bl/6 N mice on a western diet display reduced intestinal and hepatic cholesterol levels despite a plasma hypercholesterolemia. 2012 BMC Genomics pmid:22394543
Tansley G et al. Sterol lipid metabolism in down syndrome revisited: down syndrome is associated with a selective reduction in serum brassicasterol levels. 2012 Curr Gerontol Geriatr Res pmid:22649448
Lange Y et al. Activation mobilizes the cholesterol in the late endosomes-lysosomes of Niemann Pick type C cells. 2012 PLoS ONE pmid:22276143
López-Velázquez JA et al. Nuclear receptors in nonalcoholic Fatty liver disease. 2012 J Lipids pmid:22187655
Marwarha G et al. Endoplasmic reticulum stress-induced CHOP activation mediates the down-regulation of leptin in human neuroblastoma SH-SY5Y cells treated with the oxysterol 27-hydroxycholesterol. 2012 Cell. Signal. pmid:21983012
Kikuchi T et al. Increase of 27-hydroxycholesterol in the airways of patients with COPD: possible role of 27-hydroxycholesterol in tissue fibrosis. 2012 Chest pmid:22281802
Baker ME et al. 3D models of human ERα and ERβ complexed with 5-androsten-3β,17β-diol. 2012 Steroids pmid:22921477
Zheng W et al. Spatial distribution of the pathways of cholesterol homeostasis in human retina. 2012 PLoS ONE pmid:22629470
Kimura A et al. Neonatal cholestasis with increased 3β-monohydroxy-Δ⁵ bile acids in serum and urine: not necessarily primary oxysterol 7α hydroxylase deficiency. 2012 Clin. Chim. Acta pmid:22652365
Fakheri RJ and Javitt NB 27-Hydroxycholesterol, does it exist? On the nomenclature and stereochemistry of 26-hydroxylated sterols. 2012 Steroids pmid:22366074
Rosales-Corral S et al. Accumulation of exogenous amyloid-beta peptide in hippocampal mitochondria causes their dysfunction: a protective role for melatonin. 2012 Oxid Med Cell Longev pmid:22666521
Cruz P et al. 27-hydroxycholesterol and the expression of three estrogen-sensitive proteins in MCF7 cells. 2012 Oncol. Rep. pmid:22710948
McDonald JG et al. A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. 2012 J. Lipid Res. pmid:22517925
Cohen E et al. Increased Levels of Human Carotid Lesion Linoleic Acid Hydroperoxide in Symptomatic and Asymptomatic Patients Is Inversely Correlated with Serum HDL and Paraoxonase 1 Activity. 2012 J Lipids pmid:22690338
Siam A et al. Comparative modeling of 25-hydroxycholesterol-7α-hydroxylase (CYP7B1): ligand binding and analysis of hereditary spastic paraplegia type 5 CYP7B1 mutations. 2012 J Mol Model pmid:21541746
Shentu TP et al. The role of oxysterols in control of endothelial stiffness. 2012 J. Lipid Res. pmid:22496390
Bogan RL et al. Liver x receptor modulation of gene expression leading to proluteolytic effects in primate luteal cells. 2012 Biol. Reprod. pmid:22156476
Zhang X et al. Cholesterol metabolite, 5-cholesten-3β-25-diol-3-sulfate, promotes hepatic proliferation in mice. 2012 J. Steroid Biochem. Mol. Biol. pmid:22732306
Mateos L et al. side-chain-oxidized oxysterols upregulate ACE2 and Mas receptor in rat primary neurons. 2012 Neurodegener Dis pmid:22236548
Hughes TM et al. Markers of cholesterol metabolism in the brain show stronger associations with cerebrovascular disease than Alzheimer's disease. 2012 J. Alzheimers Dis. pmid:22377780
Emanuelsson I and Norlin M Protective effects of 27- and 24-hydroxycholesterol against staurosporine-induced cell death in undifferentiated neuroblastoma SH-SY5Y cells. 2012 Neurosci. Lett. pmid:22884615
Ferreiro E et al. Mitochondrial- and endoplasmic reticulum-associated oxidative stress in Alzheimer's disease: from pathogenesis to biomarkers. 2012 Int J Cell Biol pmid:22701485
Bertolotti M et al. Increased appearance rate of 27-hydroxycholesterol in vivo in hypercholesterolemia: a possible compensatory mechanism. 2012 Nutr Metab Cardiovasc Dis pmid:21546230
Wolf A et al. ABC Transporters and the Alzheimer's Disease Enigma. 2012 Front Psychiatry pmid:22675311
Schreurs BG et al. Dietary Cholesterol Concentration and Duration Degrade Long-Term Memory of Classical Conditioning of the Rabbit's Nictitating Membrane Response. 2012 Int J Alzheimers Dis pmid:22567532
Milagre I et al. Marked change in the balance between CYP27A1 and CYP46A1 mediated elimination of cholesterol during differentiation of human neuronal cells. 2012 Neurochem. Int. pmid:22185844
Li T and Chiang JY Bile Acid signaling in liver metabolism and diseases. 2012 J Lipids pmid:21991404
Poirier J et al. High-dose supplemental selenite to male Syrian hamsters fed hypercholesterolaemic diets alters Ldlr, Abcg8 and Npc1l1 mRNA expression and lowers plasma cholesterol concentrations. 2012 Br. J. Nutr. pmid:22152646
Brauner R et al. Phytosterols reduce cholesterol absorption by inhibition of 27-hydroxycholesterol generation, liver X receptor α activation, and expression of the basolateral sterol exporter ATP-binding cassette A1 in Caco-2 enterocytes. 2012 J. Nutr. pmid:22535758
Glöckner F et al. Dietary cholesterol and its effect on tau protein: a study in apolipoprotein E-deficient and P301L human tau mice. 2011 J. Neuropathol. Exp. Neurol. pmid:21412171
Gamba P et al. Interaction between 24-hydroxycholesterol, oxidative stress, and amyloid-β in amplifying neuronal damage in Alzheimer's disease: three partners in crime. 2011 Aging Cell pmid:21272192
Karuna R et al. Plasma levels of 27-hydroxycholesterol in humans and mice with monogenic disturbances of high density lipoprotein metabolism. 2011 Atherosclerosis pmid:21130455
Iborra RT et al. Advanced glycation in macrophages induces intracellular accumulation of 7-ketocholesterol and total sterols by decreasing the expression of ABCA-1 and ABCG-1. 2011 Lipids Health Dis pmid:21957962
Mateos L et al. Upregulation of brain renin angiotensin system by 27-hydroxycholesterol in Alzheimer's disease. 2011 J. Alzheimers Dis. pmid:21297254
Torres CG et al. 27-hydroxycholesterol induces the transition of MCF7 cells into a mesenchymal phenotype. 2011 Oncol. Rep. pmid:21567091
Jeitner TM et al. Oxysterol derivatives of cholesterol in neurodegenerative disorders. 2011 Curr. Med. Chem. pmid:21428891
Umetani M and Shaul PW 27-Hydroxycholesterol: the first identified endogenous SERM. 2011 Trends Endocrinol. Metab. pmid:21353593
Prasanthi JR et al. Silencing GADD153/CHOP gene expression protects against Alzheimer's disease-like pathology induced by 27-hydroxycholesterol in rabbit hippocampus. 2011 PLoS ONE pmid:22046282
Ebrahimi KB and Handa JT Lipids, lipoproteins, and age-related macular degeneration. 2011 J Lipids pmid:21822496
Honda A et al. Cholesterol 25-hydroxylation activity of CYP3A. 2011 J. Lipid Res. pmid:21576599
Vejux A et al. Contribution of cholesterol and oxysterols in the physiopathology of cataract: implication for the development of pharmacological treatments. 2011 J Ophthalmol pmid:21577274
Hong C et al. Constitutive activation of LXR in macrophages regulates metabolic and inflammatory gene expression: identification of ARL7 as a direct target. 2011 J. Lipid Res. pmid:21187453
Huwait EA et al. A novel role for c-Jun N-terminal kinase and phosphoinositide 3-kinase in the liver X receptor-mediated induction of macrophage gene expression. 2011 Cell. Signal. pmid:21070853
Lappano R et al. The cholesterol metabolite 25-hydroxycholesterol activates estrogen receptor α-mediated signaling in cancer cells and in cardiomyocytes. 2011 PLoS ONE pmid:21304949
Marwarha G et al. The oxysterol 27-hydroxycholesterol regulates α-synuclein and tyrosine hydroxylase expression levels in human neuroblastoma cells through modulation of liver X receptors and estrogen receptors--relevance to Parkinson's disease. 2011 J. Neurochem. pmid:21951066
Mateos L et al. Side chain-oxidized oxysterols regulate the brain renin-angiotensin system through a liver X receptor-dependent mechanism. 2011 J. Biol. Chem. pmid:21628469
Baker ME Insights from the structure of estrogen receptor into the evolution of estrogens: implications for endocrine disruption. 2011 Biochem. Pharmacol. pmid:21420388
Shafaati M et al. Marked accumulation of 27-hydroxycholesterol in the brains of Alzheimer's patients with the Swedish APP 670/671 mutation. 2011 J. Lipid Res. pmid:21335619
Seet RC et al. Biomarkers of oxidative damage in cigarette smokers: which biomarkers might reflect acute versus chronic oxidative stress? 2011 Free Radic. Biol. Med. pmid:21420490
Cheng D et al. Lipid pathway alterations in Parkinson's disease primary visual cortex. 2011 PLoS ONE pmid:21387008
Jusakul A et al. Mechanisms of oxysterol-induced carcinogenesis. 2011 Lipids Health Dis pmid:21388551
Coomes E et al. Methotrexate in atherogenesis and cholesterol metabolism. 2011 Cholesterol pmid:21490773
Mast N et al. Cholestenoic Acid is an important elimination product of cholesterol in the retina: comparison of retinal cholesterol metabolism with that in the brain. 2011 Invest. Ophthalmol. Vis. Sci. pmid:20881306
Zhang JH et al. The N-terminal domain of NPC1L1 protein binds cholesterol and plays essential roles in cholesterol uptake. 2011 J. Biol. Chem. pmid:21602275
Nelson ER et al. The oxysterol, 27-hydroxycholesterol, links cholesterol metabolism to bone homeostasis through its actions on the estrogen and liver X receptors. 2011 Endocrinology pmid:21933863
Leoni V and Caccia C Oxysterols as biomarkers in neurodegenerative diseases. 2011 Chem. Phys. Lipids pmid:21515244
Dasari B et al. Cholesterol-enriched diet causes age-related macular degeneration-like pathology in rabbit retina. 2011 BMC Ophthalmol pmid:21851605
Liao WL et al. Quantification of cholesterol-metabolizing P450s CYP27A1 and CYP46A1 in neural tissues reveals a lack of enzyme-product correlations in human retina but not human brain. 2011 J. Proteome Res. pmid:21049985
Ramírez C et al. ApoB100/LDLR-/- hypercholesterolaemic mice as a model for mild cognitive impairment and neuronal damage. 2011 PLoS ONE pmid:21829488
Pachikian BD et al. Hepatic n-3 polyunsaturated fatty acid depletion promotes steatosis and insulin resistance in mice: genomic analysis of cellular targets. 2011 PLoS ONE pmid:21853118
Leoni V et al. Whole body cholesterol metabolism is impaired in Huntington's disease. 2011 Neurosci. Lett. pmid:21406216
Crosignani A et al. Oxysterols in bile acid metabolism. 2011 Clin. Chim. Acta pmid:21855537
Makoukji J et al. Interplay between LXR and Wnt/β-catenin signaling in the negative regulation of peripheral myelin genes by oxysterols. 2011 J. Neurosci. pmid:21715627
Salomone S and Waeber C Selectivity and specificity of sphingosine-1-phosphate receptor ligands: caveats and critical thinking in characterizing receptor-mediated effects. 2011 Front Pharmacol pmid:21687504
Marwarha G et al. Molecular interplay between leptin, insulin-like growth factor-1, and β-amyloid in organotypic slices from rabbit hippocampus. 2011 Mol Neurodegener pmid:21651786
Bigalke B et al. Adipocytokines and CD34 progenitor cells in Alzheimer's disease. 2011 PLoS ONE pmid:21633502
Bowden KL et al. Lysosomal acid lipase deficiency impairs regulation of ABCA1 gene and formation of high density lipoproteins in cholesteryl ester storage disease. 2011 J. Biol. Chem. pmid:21757691
Bełtowski J and Semczuk A Liver X receptor (LXR) and the reproductive system--a potential novel target for therapeutic intervention. 2010 Jan-Feb Pharmacol Rep pmid:20360612
Vallim T and Salter AM Regulation of hepatic gene expression by saturated fatty acids. 2010 Apr-Jun Prostaglandins Leukot. Essent. Fatty Acids pmid:20227267
Kölsch H et al. Alterations of cholesterol precursor levels in Alzheimer's disease. 2010 Biochim. Biophys. Acta pmid:20226877
Blom T et al. FTY720 stimulates 27-hydroxycholesterol production and confers atheroprotective effects in human primary macrophages. 2010 Circ. Res. pmid:20056921
Wang YM et al. The mechanism of dietary cholesterol effects on lipids metabolism in rats. 2010 Lipids Health Dis pmid:20070910
Dasari B et al. The oxysterol 27-hydroxycholesterol increases β-amyloid and oxidative stress in retinal pigment epithelial cells. 2010 BMC Ophthalmol pmid:20836858
Berrodin TJ et al. Identification of 5α, 6α-epoxycholesterol as a novel modulator of liver X receptor activity. 2010 Mol. Pharmacol. pmid:20837678
Kumari U and Heese K Cardiovascular dementia - a different perspective. 2010 Open Biochem J pmid:20448820
Crow JA et al. Inhibition of carboxylesterase activity of THP1 monocytes/macrophages and recombinant human carboxylesterase 1 by oxysterols and fatty acids. 2010 Biochim. Biophys. Acta pmid:19761868
DuSell CD et al. The endogenous selective estrogen receptor modulator 27-hydroxycholesterol is a negative regulator of bone homeostasis. 2010 Endocrinology pmid:20501668
Ullrich C et al. Hypercholesterolemia in rats impairs the cholinergic system and leads to memory deficits. 2010 Mol. Cell. Neurosci. pmid:20696249
Marwarha G et al. Leptin reduces the accumulation of Abeta and phosphorylated tau induced by 27-hydroxycholesterol in rabbit organotypic slices. 2010 J. Alzheimers Dis. pmid:20157255
Sniderman AD et al. Regulation of plasma LDL: the apoB paradigm. 2010 Clin. Sci. pmid:19922416
Jenner AM et al. The effect of APOE genotype on brain levels of oxysterols in young and old human APOE epsilon2, epsilon3 and epsilon4 knock-in mice. 2010 Neuroscience pmid:20416362
Taylor JM et al. Overexpression of steroidogenic acute regulatory protein increases macrophage cholesterol efflux to apolipoprotein AI. 2010 Cardiovasc. Res. pmid:20083572
Weingärtner O et al. An alternative pathway of reverse cholesterol transport: the oxysterol 27-hydroxycholesterol. 2010 Atherosclerosis pmid:19801147
Seet RC et al. Oxidative damage in Parkinson disease: Measurement using accurate biomarkers. 2010 Free Radic. Biol. Med. pmid:19969070
Schüle R et al. Marked accumulation of 27-hydroxycholesterol in SPG5 patients with hereditary spastic paresis. 2010 J. Lipid Res. pmid:19812052
Crisafulli C et al. Effects of Liver x receptor agonist treatment on signal transduction pathways in acute lung inflammation. 2010 Respir. Res. pmid:20175894
Greenhill C Bone: High 27-hydroxycholesterol decreases BMD. 2010 Nat Rev Endocrinol pmid:20803803
Schneider H et al. A novel mutation in the sterol 27-hydroxylase gene of a woman with autosomal recessive cerebrotendinous xanthomatosis. 2010 Orphanet J Rare Dis pmid:20925952
Akram A et al. Increased expression of RXRα in dementia: an early harbinger for the cholesterol dyshomeostasis? 2010 Mol Neurodegener pmid:20843353
Seet RC et al. Markers of oxidative damage are not elevated in otherwise healthy individuals with the metabolic syndrome. 2010 Diabetes Care pmid:20185735
Grinberg LT and Thal DR Vascular pathology in the aged human brain. 2010 Acta Neuropathol. pmid:20155424
Olkkonen VM and Hynynen R Interactions of oxysterols with membranes and proteins. 2009 Mol. Aspects Med. pmid:19248802
Gilardi F et al. Expression of sterol 27-hydroxylase in glial cells and its regulation by liver X receptor signaling. 2009 Neuroscience pmid:19665519
Trousson A et al. Cross-talk between oxysterols and glucocorticoids: differential regulation of secreted phopholipase A2 and impact on oligodendrocyte death. 2009 PLoS ONE pmid:19956653
Solomon A et al. Plasma levels of 24S-hydroxycholesterol reflect brain volumes in patients without objective cognitive impairment but not in those with Alzheimer's disease. 2009 Neurosci. Lett. pmid:19560513
Kim WS et al. Impact of 27-hydroxycholesterol on amyloid-beta peptide production and ATP-binding cassette transporter expression in primary human neurons. 2009 J. Alzheimers Dis. pmid:19158428
Morello F et al. LXR-activating oxysterols induce the expression of inflammatory markers in endothelial cells through LXR-independent mechanisms. 2009 Atherosclerosis pmid:19426978
Björkhem I et al. Oxysterols and neurodegenerative diseases. 2009 Mol. Aspects Med. pmid:19248803
Hirayama T et al. Serum concentration of 27-hydroxycholesterol predicts the effects of high-cholesterol diet on plasma LDL cholesterol level. 2009 Hepatol. Res. pmid:19208035
Seet RC et al. Oxidative damage in dengue fever. 2009 Free Radic. Biol. Med. pmid:19427377